-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 0 | 0.00 | 23.94 | 833058 |
| 0 | 0.00 | 23.95 | 901 |
| 0 | 0.00 | 24.00 | 1806 |
| 0 | 0.00 | 24.01 | 8178 |
| 0 | 0.00 | 24.20 | 1 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 0 | 0.00 | 23.94 | 833058 |
| 0 | 0.00 | 23.95 | 901 |
| 0 | 0.00 | 24.00 | 1806 |
| 0 | 0.00 | 24.01 | 8178 |
| 0 | 0.00 | 24.20 | 1 |
| 0 | Total | Total | 0 |
| Open | 24.01 |
| Previous Close | 25.27 |
| Volume | 621.00 |
| Value (Lacs) | 0.15 |
| VWAP | 24.01 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 199 |
| High | 24.01 |
| Low | 24.01 |
| UC Limit | 26.53 |
| LC Limit | 24.01 |
| 52 Week High | 29.40 |
| 52 Week Low | 24.01 |
| Face Value | 2.00 |
| All Time High | 153.50 |
| All Time Low | 4.85 |
| 20D Avg Volume | 173,307 |
| 20D Avg Delivery(%) | -- |
| Book Value Per Share | -8.82 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | -2.94 |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 0.00 |
| Sector PE | 39.92 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
8 out of 15 years Vivimed Labs has given negative returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 17.11% (2022) | 8.45% | -10.30% (2017) | -5.91% | 0.24% |
Vivimed Labs Standalone September 2025 Net Sales at Rs 18.66 crore, down 15.8% Y-o-Y Nov 14 2025 12:45 PM
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y Jun 24 2025 10:46 AM
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y Jun 03 2025 02:07 PM
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y Mar 04 2025 01:30 PM
as per the available resources RARE Asset Reconstruction ltd had taken over the debts of the company and will work along the company on resolution of vivimed labs. there is no one time settlement as yet. View more
Posted by : aniver
Krohne Finstock and Monarch Networth are some of the Fund houses brought the stake. View more
Posted by : sonajiga
Posted by : The Fixed Income
Repost this message
Earn 11.13% Returns with a Trusted NBFC Bond Investment 10.60% NAVI FINSERV LIMITED 2027 ✔️ Coupon: 10.60% ✔️ Rating: INDIA RATING A Stable ✔️ Tenor: 1y 4m (Maturity: 21/May/2027) Senior Secured Bond | NBFC Bonds | High Return Bond | Listed A short-term, high-return opportunity designed for investors seeking both safety and growth. Benefit from predictable returns backed by a strong NBFC. Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJDc1lRPT0=/1060-navi-finserv-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Vivimed Labs | 24.01 | -4.99 | 199.08 | - | - | 0.00 | - | -31 | 116 | -5.14 |
| Sun Pharma | 1,769.80 | 1.43 | 424,634.30 | 40.64 | 5.88 | 15.13 | -2.16 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,511.50 | 0.51 | 172,859.87 | 69.56 | 11.55 | 14.63 | 11.37 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,816.00 | 0.41 | 129,150.78 | 60.35 | 17.21 | 25.17 | 11.03 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,512.90 | -0.28 | 122,207.80 | 22.46 | 3.92 | 16.90 | 2.78 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
